We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.25B
AUM Growth
+$636M
Cap. Flow
+$222M
Cap. Flow %
5.22%
Top 10 Hldgs %
17.16%
Holding
2,498
New
631
Increased
436
Reduced
367
Closed
712

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$119M
2
PFE icon
Pfizer
PFE
+$60.7M
3
CRM icon
Salesforce
CRM
+$48.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.6M
5
TSLA icon
Tesla
TSLA
+$20.5M

Sector Composition

Rank Sector Weight
1 Financials 10.77%
2 Technology 9.75%
3 Healthcare 8.93%
4 Consumer Discretionary 7.52%
5 Real Estate 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMPX.WS
1601
DELISTED
AEA-Bridges Impact Corp Warrants
IMPX.WS
$137K ﹤0.01%
+13,724
New +$11.7K
IPVIU
1602
DELISTED
InterPrivate IV InfraTech Partners Inc. Units
IPVIU
$136K ﹤0.01%
13,671
+205
+2% +$2.02K
SPIR.WS
1603
DELISTED
Spire Global, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per whole share
SPIR.WS
$136K ﹤0.01%
40,103
-27,447
-41% -$26K
FLG
1604
Flagstar Bank National Association
FLG
$5.96B
$135K ﹤0.01%
3,681
-138,872
-97% -$5.29M
FACT.U
1605
DELISTED
Freedom Acquisition I Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
FACT.U
$135K ﹤0.01%
13,764
+1,596
+13% +$15.8K
BSGAR
1606
DELISTED
Blue Safari Group Acquisition Corp. Right
BSGAR
$135K ﹤0.01%
200,000
MXCT icon
1607
MaxCyte
MXCT
$115M
$134K ﹤0.01%
13,143
-2,022
-13% -$21.7K
ABVEW
1608
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$134K ﹤0.01%
13,794
+1,358
+11% +$832
BURU.WS
1609
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$134K ﹤0.01%
+13,604
New +$8.1K
KAIRW
1610
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$134K ﹤0.01%
13,700
+1,700
+14% +$994
SBII.U
1611
DELISTED
Sandbridge X2 Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
SBII.U
$134K ﹤0.01%
14,300
DNA icon
1612
Ginkgo Bioworks
DNA
$612M
$133K ﹤0.01%
+400
New +$190K
OPFI icon
1613
OppFi
OPFI
$836M
$133K ﹤0.01%
+29,286
New +$176K
STIM icon
1614
Neuronetics
STIM
$164M
$133K ﹤0.01%
+29,764
New +$146K
MREO
1615
Mereo BioPharma
MREO
$48.4M
$132K ﹤0.01%
82,583
-4,837
-6% -$9.67K
RIGL icon
1616
Rigel Pharmaceuticals
RIGL
$756M
$132K ﹤0.01%
4,974
-1,678
-25% -$50.6K
SCS
1617
DELISTED
Steelcase
SCS
$132K ﹤0.01%
+11,292
New +$136K
AFAQU
1618
DELISTED
AF Acquisition Corp Units
AFAQU
$132K ﹤0.01%
13,257
+1,874
+16% +$18.6K
DKDCU
1619
DELISTED
Data Knights Acquisition Corp. Unit
DKDCU
$131K ﹤0.01%
11,950
IBER.WS
1620
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$131K ﹤0.01%
13,499
+400
+3% +$227
SLAC
1621
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
$129K ﹤0.01%
13,104
SCAQU
1622
DELISTED
Stratim Cloud Acquisition Corp. Unit
SCAQU
$129K ﹤0.01%
12,987
+754
+6% +$7.46K
PICC.U
1623
DELISTED
Pivotal Investment Corporation III Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
PICC.U
$129K ﹤0.01%
12,998
+1,054
+9% +$10.5K
SES icon
1624
SES AI
SES
$189M
$128K ﹤0.01%
12,826
CRHC.WS
1625
DELISTED
Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CRHC.WS
$128K ﹤0.01%
13,000

Similar funds

Boothbay Fund Management's Q4 2021 Portfolio in Review

As of Q4 2021, Boothbay Fund Management held 2,498 positions worth $4.25B, up 18% from $3.61B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boothbay Fund Management deployed $222M of net new capital in Q4 2021, opening 631 new positions and adding to 436 existing holdings. Its largest new stake was Pfizer: 1,225,403 shares worth $72.4M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $12.6M trimmed.

  • Boothbay Fund Management's largest Q4 2021 buy was Pfizer: 1,225,403 shares worth $72.4M.
  • Boothbay Fund Management added most to Amazon in Q4 2021, an estimated $119M increase.
  • Boothbay Fund Management's biggest Q4 2021 reduction was Alphabet (Google) Class C, cutting an estimated $12.6M.
  • Boothbay Fund Management fully exited Digital World Acquisition Corp. Units in Q4 2021, selling an estimated $24.6M.
  • Boothbay Fund Management's ten largest holdings make up 17% of its $4.25B portfolio in Q4 2021.
  • Boothbay Fund Management opened 631 new positions and closed 712 in Q4 2021.
  • Boothbay Fund Management's portfolio value rose 18% quarter-over-quarter to $4.25B.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.